Showing results (191-200 of 222) with videos related to
Sort By:
Pageof 23
Urology|July 1, 1983
Cryosurgery in prostatic cancer: elimination of local lesionW W Bonney, B Fallon, W L Gerber, et al.Urology|January 1, 1982
Cryosurgery in prostatic cancer: survivalW W Bonney, B Fallon, W L Gerber, et al.The Journal of Urology|February 1, 1979
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostateJ D Schmidt, W W Scott, R P Gibbons, et al.Transactions of the American Association of Genito-Urinary Surgeons|January 1, 1978
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.The Journal of Urology|June 1, 1979
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.Journal of Neuro-Oncology|November 30, 2005
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology groupMurali M Chintagumpala, Henry S Friedman, Clinton F Stewart, et al.The Journal of Urology|June 1, 1981
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostateS A Loening, W W Scott, J deKernion, et al.Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.The Lancet. Respiratory Medicine|July 24, 2021
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trialKlaus F Rabe, Bartolome R Celli, Michael E Wechsler, et al.The Journal of Urology|May 1, 1981
Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostateM S Soloway, J B deKernion, R P Gibbons, et al.Pageof 23